Latest filing published 02 Jan 2026 for Stereotaxis, Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Nachum Shamir across 5 companies, led by Luminex Corp, STRATA Skin Sciences, Inc. and Cogentix Medical Inc /DE/. Over a trading history stretching from 14 October 2014 to 2 January 2026, the count stands at 61 filings.
The open-market side counts 20 purchases for €551k alongside 6 sales for €15.3M. On balance, insiders were net sellers of €14.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 25 share grants and 6 option exercises.
The median purchase comes to €11k. On 4 out of 13 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 2 January 2026 came the latest disclosure, a share grant in Stereotaxis, Inc. The latest purchase dates back some time: it was published 1,513 days ago, on 1 September 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations